March 04, 2020
Rose
Unlike in the past, researchers who become partners with patients aren't usually the ones to break the news when a trial ends. Now, patients are more likely to see it on social media or in the 24-hour news cycle. Other public health news reports on a new CRISPR treatment for blindness, dementia, exercise's impact on immunity, LBGTQ discrimination, diet soda, and Ebola.
from Kaiser Health News https://ift.tt/3cubOF3
March 04, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
State Highlights: Colo. Republicans Refuse To Send ‘Red Flag’ Bill To Floor For Vote; Activists Protest Google Over Crisis Pregnancy Center Search Results- Precision Medicine Could Help Narrow Down Treatment For Depression, But It Will Be Tricky
- Experts Criticize Trump’s ‘America First’ Drug Plan: Europe Paying More Doesn’t Mean U.S. Will Pay Less
- Perspectives: Valeant May Be Ditching Its Name, But It Can’t Outrun Its Past Misdeeds
- Day Two Of California Workers’ Strike: ‘We Want To Make A Splash But We Don’t Want To Shut Down The Hospital’
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment